Global Ablation Devices Market
show more| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Radiation Ablators Radiation Ablators adds up considerable share to the total Ablation Devices market. Radiation Ablators can be segmented by Applications, Companies, MacroIndicators, Geographies and Products. Deep dive analysis of the key players of this domain, have been considered in this report. |
Upcoming |
|
|
Global Brachytherapy Market The global brachytherapy market was valued at $450 Million in 2013.Peers of Brachytherapy are Stereotactic Radiosurgery & Stereotactic Radiotherapy and Image Guided Radiation Therapy (IGRT) comprising respectively of the Global Radiation Ablators market. The Market is segmented on basis of products, applications and technology. Deep dive analysis of the top players of this domain, have been considered in the report. |
Upcoming |
|
|
Thermal Ablation The Global Thermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery was pegged at $9386 million in 2013 and expected to be $15480 million by 2018. The main companies operating in thermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
|
|
Non-thermal Ablation Non-thermal Ablation and Thermal Ablation adds up to total Ablation... |
Upcoming |
|
|
Electrical Ablators The global electrical ablator market, mainly driven by the increasing aging population with higher risk of chronic disease and increasing procedures through minimal invasive surgery, was valued at $785 million in 2013 and is expected to reach $1006 million by 2018. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific Corporation (U.S), AngioDynamics (U.S), and Covidien plc (Ireland). |
Upcoming |
|
|
Microwave Ablation The Global Microwave Ablation Market was pegged at $120 million in 2013 and expected to be $201 million by 2018. Microwave thermotherapy is the technology employed in Microwave Ablation. Currently there are very few players in microwave ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S). |
Upcoming |
|
|
Ultrasound Ablation The Global Ultrasound Ablation Market was pegged at $1243 million in 2013 and expected to be $2282 million by 2018. The key players in ultrasound ablation segment are InSightec(U.S), Elmed Lithotripsy(Turkey), Ethicon (J&J)(U.S), Misonix Inc.(U.S), USHIFU (U.S.), and Sonora (U.S.), a subsidiary of Misonix. |
Upcoming |
|
|
Cryoablation Cryoablation and Hydromechanical Ablation adds up to total |
Upcoming |
|
|
Hydromechanical Ablation Hydromechanical Ablation and Cryoablation adds up to total |
Upcoming |
|
|
Argon Plasma/Beam coagulators Argon Plasma/Beam coagulators and Irreversible electroporation adds up to total |
Upcoming |
|
|
Irreversible electroporation Irreversible electroporation and Argon Plasma/Beam coagulators adds up to total |
Upcoming |
|
|
Stereotactic Radiosurgery & Stereotactic Radiotherapy Stereotactic Radiosurgery & Stereotactic Radiotherapy and Brachytherapy and |
Upcoming |
|
|
Image Guided Radiation Therapy (IGRT) Image Guided Radiation Therapy (IGRT) and Brachytherapy and |
Upcoming |
|
|
High-Dose-Rate (HDR) brachytherapy High-Dose-Rate (HDR) brachytherapy and Pulsed-Dose-Rate brachytherapy and |
Upcoming |
|
|
Pulsed-Dose-Rate brachytherapy Pulsed-Dose-Rate brachytherapy and High-Dose-Rate (HDR) brachytherapy and |
Upcoming |
|
|
Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy Permanent seed brachytherapy or Low-Dose-Rate (LDR) brachytherapy and High-Dose-Rate (HDR) brachytherapy and |
Upcoming |
|
|
Electrical Ablation The Global Electrical Ablation Market was pegged at $867 million in 2013 and expected to be $1098 million by 2018. In electrical ablation market, electrical ablators accounted for a share of 90.4% in 2011. The main companies operating in this market and extensively covered in this report are ConMed Corporation (U.S), Medtronic (U.S), Boston Scientific (U.S), Angiodynamics (U.S), and Covidien (Ireland). |
Upcoming |
|
|
Hydrothermal Ablation The Global Hydrothermal Ablation Market, mainly driven by increasing aging population with higher risk of chronic diseases and increasing procedures through minimal invasive surgery. An endometrial hydrothermal balloon ablation device is the major technology indulged in hydrothermal ablation market. The main companies operating in hydrothermal ablation market and extensively covered in this report are Varian Medical systems, Elekta, Biosense Webster, St. Jude Medical Boston Scientfic, Accuray, Medtronic, CR Bard, Others. |
Upcoming |
|
|
Light/Laser Ablation The Global Light/Laser Ablation Market, was pegged at $1183 million in 2013 and expected to be $1859 million by 2018. The light/laser ablation devices consist of two types of lasers namely, cold lasers and excimer lasers. The key players operating in the optical correction Light/Laser ablation are Alcon, Abbott, Carl Zeiss followed by others. |
Upcoming |
|
|
Radiation Ablation The Global Radiation Ablation Market was pegged at $3735 million in 2013 and expected to be $5537 million by 2018. In terms of volume, the stereotactic radiotherapy and radiosurgery devices accounted for the largest volume in sales.The main companies operating in this market and extensively covered in this report are Varian Medical Systems (U.S), and Elekta (Sweden). |
Upcoming |
Ablation Devices
